Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-059636

Chief Scientific Officer acquired 57,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-18 Grant or award : show line 1 in the form +57,500 185,719 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-18 Grant or award : show line 2 in the form Stock Option (Right to Buy) +115,000 115,000 D
Loading xslF345X05/ownership.xml…